On Wednesday, Trigyn announced that the wholly-owned subsidiary of the company, Trigyn Technologies Ltd (TTL), has been awarded a contract to provide IT Technical Resource Augmentation Services by Ontario Education Collaborative Marketplace (OECM) located in the east and west geographical zones of Ontario.

Jindal Stainless Limited (JSL), India’s largest stainless steel manufacturing company, has successfully completed level-two process automation for its Argon Oxygen Decarburisation (AOD) converter at its Jajpur (Odisha) plant. 

Tata Consultancy Services (TCS), the leading global IT services, consulting and business solutions organisation and the second-largest market cap company in India, has been ranked as number 1 in HFS Top 10 Life Sciences Service Providers Report

Infosys Limited informed that it has entered into a long-term strategic partnership with American multinational conglomerate, General Electric (GE) Appliances to boost its IT operations.  

HCL Technologies (HCL), one of the leading global technology companies, on Tuesday announced that it plans to open a Global Delivery Center (GDC) in Hartford

Retirement is basically the resting period of your life. During that period, you should avoid committing any sort of financial blunder. Let’s find out what are those mistakes which you may commit unintentionally but may end up facing a lot of problems later!

The market opened in the green on February 19, 2020, overall volumes in futures & options currently stand at 2.09 crore contracts with a turnover of Rs. 14,89,668.46 crore.

The market opened in the green on February 19, 2020, overall volumes in futures & options currently stand at 2.09 crore contracts with a turnover of Rs. 14,89,668.46 crore.

The market opened in the green on February 19, 2020. The previous trading session witnessed the Sensex going down by 161.31 points to end at 40,894.38 and the Nifty was down by 53.30 points to close at 11,992.50. 

US Food & Drug Administration (USFDA) had conducted an inspection of Aurobindo Pharma’s Unit IV, a general injectable formulation manufacturing facility situated at Pashamylaram (Hyderabad) from November 4 to 13, 2019. At the end of the inspection, it was issued 'Form 483' with 14 observations.